Literature DB >> 34322723

Ibuprofen does not inhibit RhoA-mediated growth cone collapse of embryonic chicken retinal axons by LPA.

James Vinton1, Adaeze Aninweze1, Eric Birgbauer2.   

Abstract

Lysophosphatidic acid (LPA) is a bioactive lysophospholipid that causes neuronal growth cones to collapse and neurites to retract through a RhoA-ROCK mediated pathway. It has been reported that the NSAID ibuprofen improves regeneration after spinal cord injury through a mechanism of inhibiting RhoA. This leads to the hypothesis that ibuprofen should block LPA-mediated growth cone collapse. We tested this hypothesis by treating embryonic chick retinal neurons with ibuprofen followed by LPA. Retinal growth cones collapsed with LPA in the presence of ibuprofen similar to control; however, growth cone collapse was effectively blocked by a ROCK inhibitor. Thus, our results do not support the designation of ibuprofen as a direct RhoA inhibitor.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Growth cone; Ibuprofen; Lysophosphatidic acid; Retinal ganglion cells; RhoA

Year:  2021        PMID: 34322723     DOI: 10.1007/s00221-021-06172-y

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   1.972


  41 in total

Review 1.  Reaching the brain: Advances in optic nerve regeneration.

Authors:  Larry I Benowitz; Zhigang He; Jeffrey L Goldberg
Journal:  Exp Neurol       Date:  2015-12-31       Impact factor: 5.330

2.  Nonsteroidal anti-inflammatory drugs attenuate amyloid-β protein-induced actin cytoskeletal reorganization through Rho signaling modulation.

Authors:  Patricia Ferrera; Angélica Zepeda; Clorinda Arias
Journal:  Cell Mol Neurobiol       Date:  2017-01-25       Impact factor: 5.046

Review 3.  Reconnecting Eye to Brain.

Authors:  Michael C Crair; Carol A Mason
Journal:  J Neurosci       Date:  2016-10-19       Impact factor: 6.167

4.  G-protein-coupled receptor cell signaling pathways mediating embryonic chick retinal growth cone collapse induced by lysophosphatidic acid and sphingosine-1-phosphate.

Authors:  Jarod Fincher; Canaan Whiteneck; Eric Birgbauer
Journal:  Dev Neurosci       Date:  2014-08-19       Impact factor: 2.984

5.  A phase I/IIa clinical trial of a recombinant Rho protein antagonist in acute spinal cord injury.

Authors:  Michael G Fehlings; Nicholas Theodore; James Harrop; Gilles Maurais; Charles Kuntz; Chris I Shaffrey; Brian K Kwon; Jens Chapman; Albert Yee; Allyson Tighe; Lisa McKerracher
Journal:  J Neurotrauma       Date:  2011-05       Impact factor: 5.269

6.  A molecular mechanism for ibuprofen-mediated RhoA inhibition in neurons.

Authors:  John Dill; Ankur R Patel; Xiao-Li Yang; Robert Bachoo; Craig M Powell; Shuxin Li
Journal:  J Neurosci       Date:  2010-01-20       Impact factor: 6.167

Review 7.  Lysophospholipids and their receptors in the central nervous system.

Authors:  Ji Woong Choi; Jerold Chun
Journal:  Biochim Biophys Acta       Date:  2012-07-31

Review 8.  Lysophosphatidic Acid Signalling in Nervous System Development and Function.

Authors:  Eric Birgbauer
Journal:  Neuromolecular Med       Date:  2020-11-05       Impact factor: 3.843

9.  Rho signaling pathway targeted to promote spinal cord repair.

Authors:  Pauline Dergham; Benjamin Ellezam; Charles Essagian; Hovsep Avedissian; William D Lubell; Lisa McKerracher
Journal:  J Neurosci       Date:  2002-08-01       Impact factor: 6.167

Review 10.  The Struggle to Make CNS Axons Regenerate: Why Has It Been so Difficult?

Authors:  James W Fawcett
Journal:  Neurochem Res       Date:  2019-08-06       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.